期刊文献+

海绵动物抗肿瘤活性物质研究进展 被引量:1

Progress in the development of antineoplastic activity substance from marine sponge
原文传递
导出
摘要 海洋生物是抗肿瘤活性物质的重要来源。海绵动物是海洋中除珊瑚以外的第2大生物资源。近十几年来,已从不同的海绵体内分离鉴定了许多结构新颖的高活性抗肿瘤物质,显示出诱人的研究开发前景。现综述正在临床试验阶段的具有抗肿瘤活性的海绵动物提取物及其合成衍生物,以及其来源种属、化学成分及其药理作用的研究进展。 Marine organism is important source of antineoplastic active substance,sponge is the secondly larger amount of organism source besides coral in the ocean. In recent decade, several high antineoplastic active substances with novel structure are abstracted and identified from different kinds of sponges. These discovers reveal bright prospect of research and development. This article summarized antineoplastic active sponge abstracts and their synthesis derivative which still in the clinical trials ,their origins and the research development of their chemical composition and pharmacological action.
出处 《国际肿瘤学杂志》 CAS 2006年第10期733-736,共4页 Journal of International Oncology
关键词 多孔动物门 抗肿瘤药 临床试验 Porifera Antineoplastic agents Clinical trials
  • 相关文献

参考文献21

  • 1Newman DJ,Gragg GM.Marine natural products and related compounds in clinical and advanced preclinical trials.J Nat Prod,2004,67 (8):1216-1238.
  • 2Simmons TL,Andrianasolo E,McPhail K,et al.Marine natural products as anticancer drugs.Mol Cancer Ther,2005,4(2):333-342.
  • 3Nieman JA,Coleman JE,Wallace DJ,et al.Synthesis and antimitotic/cytotoxic activity of hemiasterlin analogues.J Nat Prod,2003,66 (2):183-199.
  • 4Niu C,Smith D,Zask A,et al.Tubulin inhibitors.Synthesis and biological activity of HTI-286 analogs with B-segment heterosubstituents.Bioorg Med Chem Lett,2004,14(16):4329-4332.
  • 5Loganzo F,Discafani CM,Annable T,et al.HTI-286,a synthetic analogue of the tripeptide hemiasterlin,is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and vivo.Cancer Res,2003,63 (8):1838-1845.
  • 6Hari M,Loganzo F,Annable T,et al.Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules.Mol Cancer Ther,2006,5(2):270-278.
  • 7Krishnamurthy G,Cheng W,Lo MC,et al.Biophysical characterization of the interactions of HTI-286 with tubulin heterodimer and microtubules.Biochemistry,2003,42 (46):13484-13495.
  • 8Loganzo F,Hari M,Annable T,et al.Cell resistant to HTI-286 do not overexpress P-glycoprotein but have reduced drug accumulation and a point mutation in alpha-tubulin.Mol Cancer Ther,2004,3 (10):1319-1327.
  • 9Chaulagain MR,Postema M,Valeriote F,et al.Sythesis and anti-tumor activity of β-C-glycoside analogs of the immunostimulant KRN 7000.Tetra Lett,2004,45 (41):7791-7794.
  • 10Kobayashi E,Koezuka Y.Anti-tumor activity of KRN-7000,an alphagalactosylceramide and its action mechanism.Tanpakushitsu Kakusan Koso,2000,45 (6 Suppl):1193-1198.

同被引文献40

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部